A novel dendritic cell subset involved in tumor immunosurveillance

Nature Medicine

Volumn 12, Issue 2, 2006, Pages 214-219

  Taieb, Julien ^a   Chaput, Nathalie ^a   Ménard, Cédric ^a   Apetoh, Lionel ^a   Ullrich, Evelyn ^a   Bonmort, Mathieu ^a   Péquignot, Marie ^a   Casares, Noelia ^a   Terme, Magali ^a   Flament, Caroline ^a   Opolon, Paule ^a   Lecluse, Yann ^a   Métivier, Didier ^b   Tomasello, Elena ^b   Vivier, Eric ^b   Ghiringhelli, François ^c   Martin, François ^c   Klatzmann, David ^d   Poynard, Thierry ^d   Tursz, Thomas ^a   Raposo, Graça ^e   Yagita, Hideo ^f   Ryffel, Bernard ^g   Kroemer, Guido ^a   Zitvogel, Laurence ^a   more..

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c INSERM   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e INSTITUT CURIE   (France)

^f JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; RAG2 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CELL TRANSFER; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; INTERFERON PRODUCTION; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD11C; ANTIGENS, CD45; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DNA-BINDING PROTEINS; FEMALE; INTERFERON TYPE II; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; MICROSCOPY, ELECTRON; NEOPLASMS, EXPERIMENTAL; RECEPTORS, INTERLEUKIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 32244445715     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1356     Document Type: Article

References (26)

1. Smyth, M.J. et al. Nature's TRAIL - on a path to cancer immunotherapy. Immunity 18, 1-6 (2003).
2. Yagita, H., Takeda, K., Hayakawa, Y., Smyth, M.J. & Okumura, K. TRAIL and its receptors as targets for cancer therapy. Cancer Sci. 95, 777-783 (2004).
3. Shankaran, V. et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107-1111 (2001).
4. Kaplan, D.H. et al. Demonstration of an IFNγ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95, 7556-7561 (1998).
5. Diefenbach, A., Jensen, E.R., Jamieson, A.M. & Raulet, D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413, 165-171 (2001).
6. + T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I. J. Exp. Med. 179, 661-672 (1994).
7. Ruggeri, L. et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097-2100 (2002).
8. Smyth, M.J. et al. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J. Exp. Med. 200, 1325-1335 (2004).
9. Borg, C. et al. Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects. J. Clin. Invest. 114, 379-388 (2004).
10. Smyth, M.J. et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193, 661-670 (2001).
11. Shin, E.C. et al. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Int. J. Cancer 93, 262-268 (2001).
12. Pelayo, R. et al. Derivation of two categories of plasmacytoid dendritic cells in murine bone marrow. Blood 105, 4407-4415 (2005).
13. Chan, C.W. et al. IFN producing Killer-dendritic cells directly link innate and adaptative immunity. Nat. Med. (in the press).
14. Durali, D. et al. In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood 102, 4084-4089 (2003).
15. Munder, M., Mallo, M., Eichmann, K. & Modolell, M. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation. J. Exp. Med. 187, 2103-2108 (1998).
16. Fukao, T., Matsuda, S. & Koyasu, S. Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells. J. Immunol. 164, 64-71 (2000).
17. Ohteki, T. et al. Interleukin 12-dependent Interferon gamma production by CD8alpha+ lymphoid dendritic cells. J. Exp. Med. 189, 1981-1986 (1999).
18. Trinite, B., Voisine, C., Yagita, H. & Josien, R. A subset of cytolytic dendritic cells in rat. J. Immunol. 165, 4202-4208 (2000).
19. Homann, D. et al. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16, 403-415 (2002).
20. Hochrein, H. et al. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J. Immunol. 166, 5448-5455 (2001).
21. Vidalain, P.O. et al. Measles virus induces functional TRAIL production by human dendritic cells. J. Virol. 74, 556-559 (2000).
22. + T-cell tolerance. Blood 105, 1135-1143 (2005).
23. Mohty, M. et al. Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia. Blood 103, 4666-4668 (2004).
24. Ray, C.A. et al. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69, 597-604 (1992).
25. Schneider, P. et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7, 831-836 (1997).
26. Bonnotte, B. et al. Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system. J. Immunol. 167, 5077-5083 (2001).